Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2 by Emilien Ezine, Céleste Lebbe, Nicolas Dumaz

Get full text

European Journal of Skin Cancer Editorial by Dirk Schadendorf, Celeste Lebbe, Paul Lorigan, Susana Puig

Get full text

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy by Ahlem Jebali, Maxime Battistella, Céleste Lebbé, Nicolas Dumaz

Get full text

Pigmented Bowen’s disease presenting with a “starburst” pattern by Maione Vincenzo, Enzo Errichetti, Sara Laurent Roussel, Celeste Lebbé

Get full text

Update on the treatment of BRAFmut metastatic melanoma and future perspectives by Peter Mohr, Inès Nakouri, Sylvie Pfersch, François Denjean, Celeste Lebbé

Get full text

Bortezomib Does Not Prevent the Occurrence of Kaposi’s Sarcoma in Patients with Haematological Malignancies: Two Case Reports by Nathalie Chavarot, Celeste Lebbe, Eric Thervet, Didier Bouscary, Alexandre Karras

Get full text

Erratum to “Line-field confocal optical coherence tomography (LC-OCT) features of a melanotic macule of the lip” EJC Skin Cancer 2 (2024) 100016 by Barouyr Baroudjian, Clothilde Raoux, Perla El Zeinaty, Camille Gandon, Celeste Lebbé

Get full text

Line-field confocal optical coherence tomography (LC-OCT) features of a melanotic macule of the lip by Barouyr Baroudjian, Clothilde Raoux, Perla El Zeinaty, Camille Gandon, Celeste Lebbé

Get full text

Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients by Aline Rangel-Pozzo, Janine Wechsler, Jessica Groult, Laetitia Da Meda, Celeste Lebbe, Sabine Mai

Get full text

The “Personalising Actinic Keratosis Treatment for Immunocompromised Patients” (IM-PAKT) Project: An Expert Panel Opinion by Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F. L. Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal

Get full text

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors by Julie Delyon, Selma Becherirat, Anissa Roger, Mélanie Bernard-Cacciarella, Coralie Reger De Moura, Baptiste Louveau, Samia Mourah, Céleste Lebbé, Nicolas Dumaz

Get full text

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients by Barouyr Baroudjian, Celeste Lebbe, Stefania Cuzzubbo, Pauline Tetu, Sarah Guegan, Renata Ursu, Catherine Belin, Lila Sirven Villaros, Julie Mazoyer, Coralie Lheure, Antoine F Carpentier

Get full text

Erratum to ‘Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin’ [EJC Skin Cancer 1 (2023) 100002] by Yaëlle Bellahsen-Harrar, Marie Boisson, Baptiste Louveau, Barouyr Baroudjian, Thomas Aparicio, Valentine Ferré, Yann Parc, Aurélie Sadoux, Fanélie Jouenne, Maxime Battistella, Céleste Lebbé, Samia Mourah

Get full text

Molecular profiling of anal Paget’s disease and underlying anal adenocarcinoma highlights their common origin by Yaëlle Bellahsen-Harrar, Marie Boisson, Baptiste Louveau, Barouyr Baroudjian, Thomas Aparicio, Valentine Ferré, Yann Parc, Aurélie Sadoux, Fanélie Jouenne, Maxime Battistella, Céleste Lebbé, Samia Mourah

Get full text

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective... by David Russo, Stéphane Dalle, Olivier Dereure, Laurent Mortier, Sophie Dalac-Rat, Caroline Dutriaux, Marie-Thérèse Leccia, Marie-Thérèse Leccia, Delphine Legoupil, Henri Montaudié, Eve Maubec, Julie De Quatrebarbes, Jean-Philippe Arnault, Florence Granel Brocard, Philippe Saïag, Brigitte Dreno, Clara Allayous, Clara Allayous, Bastien Oriano, Wendy Lefevre, Céleste Lebbé, Céleste Lebbé, Lise Boussemart, Lise Boussemart

Get full text

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program by Celeste Lebbe, Paolo Antonio Ascierto, Shahneen Sandhu, Vijay Kasturi, Luc Dirix, Paul Nathan, Subramanian Hariharan, Giovanni Grignani, Eyal Fenig, Rodrigo Munhoz, Elena Benincasa, Sarah Flaskett, Josh Reed, Arne Engelsberg

Get full text

Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides by Jérémie Delaleu, Maxime Battistella, Caroline Ram‐Wolff, Hélène Moins‐Teisserenc, Van‐Anh Ta, Marie Roelens, Jacqueline Rivet, Céleste Lebbé, Samia Mourah, Baptiste Louveau, Jean‐David Bouaziz, Martine Bagot, Adèle deMasson

Get full text

French dermatologists' opinions and practices with regard to adjuvant therapy in stage III melanoma by Marion Rolland, Emmanuel Oger, Monica Dinulescu, Thierry Lesimple, David Russo, Marc Pracht, Marc Porneuf, Sophie Dalac, Damien Giacchero, Thomas Jouary, Celeste Lebbé, Marie-Thérèse Leccia, Eve Maubec, Nicolas Meyer, Laurent Mortier, Alain Dupuy

Get full text

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study by Jessica C Hassel, Celeste Lebbe, Paul Nghiem, Felix Kiecker, Sandra P D'Angelo, Andrew S Brohl, Sara Georges, Parantu Shah, Barbara Ellers-Lenz, Gülseren Güzel, Laurent Mortier, Jean-Jacques Grob, Nicola Fazio, Natalie Prinzi, Glenn J Hanna

Get full text

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II tria... by Celeste Lebbe, Parminder Singh, Omid Hamid, Frances A Collichio, Igor Puzanov, Merrick Ross, Theodore Logan, Philip Friedlander, Claus Garbe, Janice M Mehnert, John Glaspy, Axel Hauschild, Wendy Snyder, Jason A Chesney, Mohammed M Milhem, Harshada Joshi

Get full text